A transgenic rabbit model for human hypertrophic cardiomyopathy

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Animal Models of Disease

Background:

• Hypertrophic cardiomyopathy (HCM) is a genetic heart disease often caused by mutations in sarcomeric protein genes.
• Understanding the molecular mechanisms underlying HCM is crucial for developing effective treatments.

Purpose of the Study:

• To develop a novel transgenic rabbit model that accurately replicates human HCM phenotypes.
• To investigate the pathological consequences of a specific beta-myosin heavy chain (MyHC) mutation (R400Q) in vivo.

Main Methods:

• Generation of transgenic rabbits expressing wild-type or mutant human beta-MyHC (R400Q) under a murine promoter.
• Confirmation of transgene expression using Northern blotting and 2D gel electrophoresis with immunoblotting.
• Assessment of cardiac structure and function through histological analysis and echocardiography.

Main Results:

• Mutant beta-MyHC transgenic rabbits exhibited significant cardiac hypertrophy, myocyte disarray, and increased interstitial collagen.
• Increased septal thickness, posterior wall thickness, and left ventricular mass were observed in mutant rabbits.
• Mutant rabbits showed a higher incidence of premature death compared to wild-type and non-transgenic littermates.

Conclusions:

• Cardiac expression of the beta-MyHC-Q(403) mutation in transgenic rabbits successfully recapitulates key pathological features of human HCM.
• This model provides a valuable platform for studying HCM pathogenesis and testing therapeutic strategies.